Best Oral GLP-1 Pill Providers Online (2026)
Compare reviewed GLP-1 weight loss providers, billing commitments, and the treatments their links actually offer.
We may earn a commission through provider links. Matching affiliate offers and editorial priorities affect inclusion and suggested order in commercial guides. Scores are not clinical endorsements. Disclosure · Methodology
Compare the options first
Full comparison & price terms ↓A short preview in editorial order—not a guarantee of the cheapest total bill. Read the commitment terms before choosing.
From $198/mo
Lower listed rate · not necessarily monthly billing
FDA-approved oral semaglutide
From $149/mo
Lower listed rate · not necessarily monthly billing
Oral GLP-1 option
From $49/mo
Lower listed rate · not necessarily monthly billing
Oral tirzepatide from $49
The Ranking
FuturHealth
GLP-1 weight-loss platform combined with personalised nutrition and fitness coaching.
Editor’s take: Coaching is the differentiator. If you're going to use it, FuturHealth pulls ahead of cheaper, drug-only competitors. If you won't, save the money.
Full review →
SkinnyRx
Clinician-guided GLP-1 platform with both compounded and brand-name access plus overnight shipping.
Editor’s take: Premium positioning, premium catalog. If you want maximum optionality across GLP-1 modalities, this is the deepest menu on the site. The premium catalog comes at a premium price. If you want maximum optionality across GLP-1 modalities, SkinnyRx is the deepest menu on the site; if you want the lowest cost, look at Trimi or HealthRx.
Full review →
Shed Rx
GLP-1 clinic offering injections, oral semaglutide, drops, and lozenges plus brand-name Wegovy and Zepbound.
Editor’s take: A reasonable mid-priced pick when delivery flexibility matters. Verify auto-billing terms before signing up given mixed reports. Verify auto-billing terms before signing up given mixed reviews on cancellation. If delivery flexibility is your priority, compare ShedRx against Breeze Meds which also offers sublingual tirzepatide.
Full review →
Curex
Transparent-pricing compounded GLP-1 clinic with three delivery formats — injectable, oral dissolving tablet (ODT), and sublingual drops — starting from $149/mo with no membership fees.
Editor’s take: A competitively priced compounded GLP-1 clinic with genuinely differentiated delivery formats. The ODT and sublingual drop options are rare in the market and make Curex a standout for needle-averse patients. No membership fees and third-party lab testing add to the transparency story.
Full review →
Telos Rx
Peptide-led integrated telehealth covering GLP-1 weight loss, anti-aging, and sexual wellness under one care team — oral tirzepatide from $49/mo, injectable from $139/mo, with flat pricing and no dose surcharges.
Editor’s take: A genuinely integrated peptide clinic with competitive first-month pricing, especially on longer plans. The breadth of offerings (GLP-1 injectable and oral, sermorelin, PT-141, NAD+) under one roof is unusual for a single telehealth provider. The named 503A/503B pharmacy partners (VialsRX, Jungle Jim's) and LegitScript certification add transparency. Watch for the gap between headline first-month prices and ongoing costs on shorter plans.
Full review →
Terra Health
Black and Latino-founded GLP-1 telehealth clinic offering affordable compounded semaglutide and tirzepatide with a focus on equitable access and culturally responsive care.
Editor’s take: A mission-driven GLP-1 clinic with a genuine focus on health equity. The $249/mo all-inclusive pricing is competitive, and the culturally responsive care model fills a real gap in the telehealth market.
Full review →
MadeMed
Doctor-backed compounded telehealth across GLP-1, peptides, NAD+, and sexual health, with oral alternatives to injections.
Editor’s take: A solid compounded-only generalist with one of the lowest entry prices for oral semaglutide. The NAD+ and sermorelin menu is a real differentiator for longevity-curious buyers.
Full review →2026 Price Comparison. Published Price Terms
Compare the lower and higher listed rates, then read the billing conditions. A listed monthly equivalent may require prepayment; visits, medication, membership, or shipping can cost extra.
Recorded price-check dates: 26 June 2026 – 13 July 2026. Per-provider dates below; these are not a guarantee of today's checkout price.
Rates use different billing terms and are not necessarily all-in or month-to-month. Confirm total charges and cancellation terms. Compounded medications are not FDA-approved finished drugs; pharmacy type alone does not establish legality or clinical suitability.
3 providers · Trustpilot scores are customer opinions, not treatment results.
| Provider & billing terms | Lower listed rate | Higher listed rate | Pharmacy | Reviews & price check | Actions |
|---|---|---|---|---|---|
| FuturHealthOnly Verified Brand-Name Pill FDA-approved oral semaglutide | Lower listed rateFrom $198/mo | Higher listed rateFrom $299/mo | PharmacyBrand-name Wegovy pill | 4.7/5 15,774 reviews 26 June 2026 | Go FuturHealthRead full review |
| SkinnyRx Oral GLP-1 option | Lower listed rateFrom $149/mo | Higher listed rateFrom $249/mo | PharmacyCompounded oral 503A | 4.8/5 5,335 reviews 26 June 2026 | Go SkinnyRxRead full review |
| Telos Rx Oral tirzepatide from $49 | Lower listed rateFrom $49/mo | Higher listed rateFrom $199/mo | PharmacyCompounded oral 503A | 4.9/5 3 reviews 13 July 2026 | Go Telos RxRead full review |
Provider links may earn a commission. Rate sorting compares the displayed numbers, not equivalent treatment plans or total commitments. How we check price terms →
What to know before choosing
Not everyone wants a weekly injection. With the FDA approving the first oral GLP-1 for weight loss (the Wegovy tablet) in December 2025, the needle-free path is finally real — and a growing list of telehealth providers now offer some form of oral GLP-1, from brand-name oral semaglutide to compounded oral dissolving tablets (ODTs). This guide ranks the providers that actually dispense an oral GLP-1, with verified pricing and a clear note on what form each one offers. Every provider below routes to a link we've checked.
"Oral GLP-1" is not one product — it covers several meaningfully different things, and the distinction matters before you sign up. One is brand-name oral semaglutide, including Rybelsus for type 2 diabetes. Another is compounded oral or dissolving semaglutide (ODT/sublingual), prepared by compounding pharmacies. A third is Foundayo (orforglipron), the once-daily oral GLP-1 receptor agonist approved by the FDA on April 1, 2026 for chronic weight management in eligible adults.
The trade-off versus injections is real on both sides. Oral GLP-1s remove the needle and the refrigerated-pen logistics, which matters for needle-averse patients and frequent travellers. But brand-name oral semaglutide requires a strict fasted-window protocol (taken on an empty stomach with no more than 4 oz of water, 30+ minutes before anything else), and compounded oral/ODT products are not FDA-approved finished drugs. Efficacy for the 25 mg oral Wegovy tablet looked broadly comparable to the injection in its pivotal trial, but the daily compliance burden is higher.
Below we rank the telehealth providers that make an oral GLP-1 realistic today, note exactly what form each offers, and break down who each option suits. No provider paid for placement; the ranking reflects our current editorial assessment of price transparency, the legitimacy of the oral product offered, and clinical oversight.
Methodology
We scored each provider on four axes: the type of oral GLP-1 offered (FDA-approved brand-name tablet vs compounded oral/ODT), price transparency, pharmacy disclosure for any compounded product, and clinical oversight including the fasted-window guidance the oral route demands. Providers offering only injectables were excluded; providers marketing 'compounded oral semaglutide for weight loss' were noted given the post-shortage legal constraints.
What the Studies Actually Show
The evidence below includes oral semaglutide and primary-source ATTAIN-1 data for FDA-approved Foundayo. The ATTAIN-1 estimands are identified separately and are not head-to-head comparisons with other GLP-1 trials.
| Endpoint | Finding |
|---|---|
| Mean weight change (OASIS 4)1 | Oral semaglutide 25 mg produced 13.6% mean weight loss at 64 weeks by the treatment-policy estimand, versus 2.2% with placebo |
| Population and study limits1 | OASIS 4 studied adults with overweight or obesity without diabetes. It was a placebo-controlled trial, not a direct comparison with injectable semaglutide or tirzepatide |
| Formulation limits1 | Results from the studied oral tablet regimen do not establish equivalent outcomes for compounded oral drops, sublingual preparations, or other formulations |
| Mean body-weight change at 72 weeks (ATTAIN-1, treatment-regimen estimand)4 | −11.2% with orforglipron 36 mg once daily vs −2.1% with placebo in adults with obesity without diabetes. |
| Mean body-weight change at 72 weeks (ATTAIN-1, efficacy estimand)4 | −12.4% with orforglipron 36 mg once daily. This estimand assumes participants remained on assigned treatment without prohibited weight-management treatment. The efficacy and treatment-regimen estimands answer different questions and should not be treated as interchangeable figures. |
Frequently Asked Questions
Is there a GLP-1 weight-loss pill I can get online?
Yes. As of December 2025 the FDA approved the oral Wegovy tablet (semaglutide 25 mg) for weight management, and telehealth providers such as FuturHealth have begun dispensing it. Several other platforms offer compounded oral or dissolving (ODT) semaglutide. Brand-name oral semaglutide is FDA-approved; compounded oral products are not FDA-approved finished drugs.
Which is the best oral GLP-1 pill provider?
It depends on whether you want the FDA-approved brand-name tablet or a lower-cost compounded oral option. FuturHealth is the provider we've verified is dispensing the brand-name Wegovy pill with bundled coaching for the strict fasted-window protocol. For lower-cost compounded oral or dissolving semaglutide, MadeMed and Terra Health offer transparent flat pricing. The right pick depends on your budget and how much you value FDA approval.
Is the oral GLP-1 pill as effective as the injection?
For the FDA-approved oral Wegovy tablet, the pivotal trial reported weight loss broadly in the same range as injectable Wegovy, though the two were not compared head-to-head and real-world results hinge on strict adherence to the fasted-window dosing. Compounded oral and dissolving products do not have comparable trial evidence. The route is needle-free but the daily compliance burden is higher than a weekly shot.
Can I get compounded oral semaglutide for weight loss in 2026?
This is legally constrained. Now that brand-name oral semaglutide for weight loss is FDA-approved and commercially available, the shortage and personalisation pathways that previously justified compounding the obesity indication are narrower. Some providers offer compounded oral or dissolving semaglutide; ask any provider directly how they meet the legal requirement before signing up.
What about orforglipron and other new oral GLP-1 pills?
Foundayo (orforglipron) is an FDA-approved small-molecule oral GLP-1 receptor agonist that may be taken with or without food. In the 72-week ATTAIN-1 trial, 36 mg produced −11.2% mean body-weight change by the treatment-regimen estimand and −12.4% by the efficacy estimand. We have not independently verified a provider-specific Foundayo affiliate destination, so this guide does not recommend a telehealth provider for it.
- OASIS 4 — NEJM 2025 · Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity. OASIS 4: 64-week placebo-controlled trial; the treatment-policy estimand showed 13.6% mean weight loss.
- ATTAIN-1 — NEJM 2025 · Wharton S et al. Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist for Obesity Treatment. N Engl J Med. 2025;393:1796–1806.
RxNotebook is an editorial publication, not a medical practice. We are not affiliated with the cited studies; source material does not endorse the providers shown. This is general information, not medical advice.